Nickerson P A, Yang F
Department of Pathology, State University of New York, Buffalo 14214.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59(4):215-21. doi: 10.1007/BF02899407.
A low dose of nitrendipine (1 mg/kg twice daily) ameliorated the percent incidence and severity of vascular lesions in the kidney and heart induced by deoxycorticosterone (DOC). Less protection was offered by administration of 1 mg/kg of the calcium antagonist once daily. A lower dose of the antagonist (0.5 mg/kg) administered twice daily produced almost no protection against myocardial scars, but the percent incidence and severity of renal tubular casts and glomerular changes were similar to those following injection of 1 mg/kg of the antagonist twice daily. DOC induced hypertrophy of the media in aorta, coronary artery and renal interlobular artery and renal arteriole. Neither 1 mg/kg once or twice daily nor 0.5 mg twice daily of calcium antagonist modified the hypertrophy of the arterial vasculature in the hypertensive DOC group. We conclude that a low dose of the calcium antagonist dissociates at least in part lesions but not hypertrophy from the increased systolic blood pressure, because the antagonist protects against vascular lesions induced by the hypertension. The antagonist likely acts on the endothelial cell of the vessels alone or combined with an effect on the vascular smooth muscle cells.
低剂量的尼群地平(每日两次,每次1毫克/千克)可改善脱氧皮质酮(DOC)诱导的肾脏和心脏血管病变的发生率及严重程度。每日一次给予1毫克/千克的钙拮抗剂提供的保护作用较小。每日两次给予较低剂量的拮抗剂(0.5毫克/千克)对心肌瘢痕几乎没有保护作用,但肾小管铸型的发生率及严重程度和肾小球变化与每日两次注射1毫克/千克拮抗剂后的情况相似。DOC可导致主动脉、冠状动脉、肾小叶间动脉和肾小动脉的中膜肥厚。高血压DOC组中,每日一次或两次给予1毫克/千克以及每日两次给予0.5毫克的钙拮抗剂均未改变动脉血管的肥厚情况。我们得出结论,低剂量的钙拮抗剂至少部分地使病变与收缩压升高脱钩,但不能使肥厚与收缩压升高脱钩,因为该拮抗剂可预防高血压诱导的血管病变。该拮抗剂可能仅作用于血管内皮细胞,或与对血管平滑肌细胞的作用共同发挥作用。